NR4A1 and carcinoma: Some interesting facts about the molecular interaction of hormone receptors (particularly ER) and HER2 have been reported to date: estrogen generally downregulates HER2 expression [33,34], a mechanism that does not seem to be relevant in HR/HER2 co-expressing carcinomas from hitherto unknown reasons [16].